Congenital heart disease is the most frequently occurring congenital disorder affecting≈
0.8% of live births. Thanks to great efforts and technical improvements, including the …

The population of patients with congenital heart disease (CHD) is continuously increasing
with more and more patients reaching adulthood. A significant portion of these young adults …

Background and Purpose: This scientific statement provides an interprofessional,
comprehensive review of evidence and recommendations for indications, duration, and …

Interventions in adults with congenital heart disease (ACHD) focus on surgical and
percutaneous interventions in light of rapidly evolving ACHD clinical practice. To bring rigour …

Background While transcatheter device closure of ventricular septal defects (VSDs) is
gaining popularity, concerns remain about adverse events; particularly heart block in peri …

Three-dimensional echocardiography (3DE) has become important in the management of
patients with congenital heart disease (CHD), particularly with pre-surgical planning …

OBJECTIVE: The development of the Amplatzer Membranous VSD Occluder (AGA Medical
Corp, Plymouth, Minn) for closure of the perimembranous ventricular septal defect has …

BACKGROUND: Ventricular septal defect (VSD) is the most commonly recognized
congenital heart defect. With the development of device closure for intracardiac defects, we …

Objectives: The objective of this study was to evaluate the safety and efficacy of the surgical
versus transcatheter approach to correct perimembranous ventricular septal defects …

A ventricular septal defect (VSD) is a hole between the ventricles. They are characterized
into anatomic types based on their location relative to the components of the right ventricle …